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The therapeutic paradigm for neck metastasis of squamous 
cell carcinoma (SCC) in the lower level of the mouth has 
changed due to survival. Aim: A comparative study between 
radical (RND) versus selective neck dissection (SND). 
Material and Method: An analysis of mouth SCC in the 
lower level of the mouth in 460 files from the Head & Neck 
and ORL Department of the Heliopolis Hospital, from 1978 
to 2002. In the RND the metastathic rate in levels IV and V 
was assessed; in the SND the presence and site of recurrence 
was identified. The chi square test with the Yates correction 
was the chosen statistical method. Results: In the RND the 
metastatic rates were 5.8% (level IV) and 4.6% (level V) for 
cNO cases, and 9.9% (level IV) and 5.9%(level V) for cN+ 
cases; for level I only the rates were 11,0% for cNO cases and 
5.5% for cN+ cases. In the SND the number of recurrences 
was 4 (4.1%) in 97 neck dissections (pNO) and 2 (10%) in 
20 neck dissections (pN+). There was no advantage in using 
radiation compared to non-irradiated cases (5.6% and 5.7%). 
Conclusion: The SND may be used for SCC of the lower 
level of the mouth.
Keywords: mouth, key words: neck dissection, radical, 
supraomohyoid.
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INTRODUCTION
The presence of lymphatic cervical metastases in 
patients bearing epidermoid carcinoma (or squamous cell 
carcinoma) of the lower portion of the mouth predicts an 
unfavorable prognosis. This explains a constant concern 
and strategy changes in the treatment of the neck with this 
malignancy. Originally, radical neck dissection was the rule 
for therapy.1 This approach started to be questioned due 
to lack of disease control2 and increased knowledge about 
visceral compartments that justified the preservation of 
non-lymphatic structures of the neck (jugular vein, spinal 
nerve and the sternocleidomastoid muscle).3,4 After the 
1970s, new studies revealed that lymphatic metastasizing 
into various neck regions followed a selective pattern 
according to the site of the primary tumor.5-7 This made it 
possible to progressively systematize selective neck dis-
section, where results were similar those obtained from 
radical neck dissection, although some of the lymphatic 
chains were not resected.8 These findings enabled physi-
cians to recommend selective neck dissection with onco-
logical safety. Initially, this procedure was used in necks 
with no metastatic lymph nodes (cN0) and in those cases 
with lymph node metastases up to 2 cm with no rupture 
of the capsule (pN1).9-17 These studies underlined our 
proposition to change the extension of neck dissection 
for the surgical treatment of necks with clinical metastases 
(cN1) from squamous cell carcinoma in the lower region 
of the mouth. We based our proposition on the follow-up 
of patients and the diagnosis of lymph node recurrence 
in those anatomical regions not included in the selective 
procedure.
MATERIAL AND METHOD
A retrospective analysis was made of 460 charts of 
patients diagnosed with squamous cell carcinoma in the 
lower region of the mouth. The Research Ethics Committee 
approved the trial (number 353). Eligibility criteria were 
as follows: previously untreated patients with squamous 
cell carcinoma in the lower region of the mouth (tongue, 
floor of the mouth, retromolar region and the lower gin-
giva) that underwent radical or selective (supraomohyoid) 
neck dissection, with a minimum follow-up period of 12 
months or until death.18 Patients were classified according 
to age, sex, site of the primary tumor, and clinical and 
pathological staging (TNM 2002). The mean age was 54.5 
years, the median age was 53 years (Q25-75% = 47 - 62), 
the minimum age was 22 years and the maximum age 
was 87years. There were 406 men (88.3%) and 54 women 
(11.7%), an 8:1 ratio. The tumor sites were the floor of the 
mouth (180 cases, 39.1%), the tongue (136 cases, 29.6%), 
the retromolar region (74 cases, 16.1%) and the lower 
gingiva (70 cases, 15.2%).
Staging of the primary tumor was as follows: 14 
cases were T1 (3.0%), 157 cases were T2 (34.1%), 146 
cases were T3 (31.8%), 138 cases were T4 (30.0%) and 
five cases were 5 Tx (1.1%). Clinical staging of the neck 
was as follows: 227 cases were cN0 (49.3%) and 233 cases 
were cN+ (50.7%), of which 119 cases were N1 (25.9%), 
18 cases were N2a (3.9%), 58 cases were N2b (12.6%), 23 
cases were N2c (5.0%), 14 cases were N3 (3.0%) and 1 case 
was Nx (0.2%) (Table 1). Patients were grouped according 
to the clinical stage of the disease, as follows: Stage I - 8 
cases (1.7%), Stage II - 101 cases (21.9%), Stage III - 152 
cases (33.1%) and Stage IV - 196 cases (42.6%). Clinical 
staging was impossible in three cases (0.7%).
The pN staging was as follows: 214 cases (46.5%) 
were pN0 and 246 cases (53.5%) were pN+, of which 62 
cases (13.5%) were pN1, 7 cases (1.5%) were N2a, 138 
cases (30.0%) were pN2b, 23 cases (5.0%) were pN2c, 5 
cases (1.1%) were pN3 and 11cases (2.4%) were unclassi-
fiable (pNx) (Table 2).
All of the patients underwent elective/therapeutic 
treatment of the primary tumor and the neck simultaneou-
sly. Surgery was unilateral or bilateral radical or selective 
(supraomohyoid) neck dissection. Local, regional and dis-
tance recurrences were assessed, as were second primary 
tumors and their sites. In regional recurrences, control 
rates of the primary tumor, the site of recurrence (within 
or out of the operated area) and the rate of postoperative 
radiotherapy were evaluated.
Statistics comprised the descriptive method; quali-
tative variables were evaluated using the chi-square test 
with the Yates correction. The Statistica 5.0 (Statsoft, USA) 
software was used.
RESULTS
There were 445 radical neck dissections, distributed 
according to metastasizing levels (Table 3). In 273 cases N+ 
that excluded 2Nx, the cases were distributed according to 
those levels and TNM staging (Table 4). The distribution of 
lymph nodes according to the four sites of the lower region 
of the mouth was sub-classified for the 387 radical neck 
dissections (Table 5). In supraomohyoid neck dissections 
(among the total 573), 22 cases (17.1%) presented metasta-
tic lymph node involvement (pN+); 106 cases (82.9%) had 
no metastases on histopathology (pN0). The rates of local, 
regional and local-regional recurrence are shown on Table 
6 for those 106 pN0 cases (82.9%). There was regional 
recurrence in 27 cases (6.1%) of 445 neck dissections. Of 
these 7 cases (4.0%) were pN0 and 20 cases (7.3%) were 
pN+. In those 7 pN0 cases, 5 cases recurred within the 
dissection area and 2 recurred in the contralateral side of 
the neck; these 7 were not irradiated. Of the 20 pN+ ca-
ses, 11(2,2%) occurred in the neck, 2 within the dissected 
area and 9 in the contralateral side of the neck; 4 of these 
cases were irradiated. Regional recurrence occurred in 9 
cases (7.1%) of 128 supraomohyoid neck dissections, of 
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Table 1. Clinical T and N staging (cT and cN) of 460 patients with squamous cell carcinoma of the oral cavity.
cN0 cN1 cN2a cN2b cN2c cN3 cNx TOTAL%
cT1 8 1 0 2 1 1 1 14(3,0%)
cT2 101 38 2 11 1 4 0 157(34,1%)
cT3 71 41 6 20 5 3 0 146(31,8%)
cT4 45 37 9 25 16 6 0 138(30,0%)
cTx 2 2 1 0 0 0 0 5(1,1%)
TOTAL
227
(49,3%)
119
(25,9%)
18
(3,9%)
58
(12,6%)
23
(5,0%)
14
(3,0%)
1
(0,2%)
460
(100,0%)
T = staging of the primary tumor - TNM. N = staging of lymph node metastasis - TNM
Table 2. Comparative study of cN and pN parameters.
Clinical N 
stage
Stage N, on pathology
TOTAL
pN0 pN1 pN2a pN2b pN2c pN3 pNx
N0
152 
(66,9%)
29 
(12,8%)
0
41 
(18,1%)
1
(0,4%)
0
4
(1,8%)
227
(100%)
N1 41 (34,5%)
19
(15,9%)
2
(1,7%)
48 
(40,3%)
4
(3,4%)
0
5
(4,2%)
119
(100%)
N2a
2
(11,1%)
4 
(22,2%)
2 
(11,1%)
7
 (38,9%)
3
 (16,7%)
0 0
18
(100%)
N2b
11 
(18,9%)
8 
(13,8%)
2
(3,5%)
30 
(51,7%)
5
(8,6%)
0
2
(3,5%)
58
(100%)
N2c
6
(26,1%)
2
(8,7%)
0
5 
(21,7%)
10 
(43,5%)
0 0
23
(100%)
N3
2
(14,3%)
0
1
(7,1%)
6 
(42,9%)
0
5 
(35,7%)
0
14
(100%)
Nx 0 0 0
1
(100%)
0 0 0
01
(100%)
TOTAL 214 62 7 138 23 5 11 460
N = clinical staging of lymph node metastasis - TNM, pN = staging of lymph node metastasis on pathology - TNM
Table 3. Distribution of cervical metastases in 445 radical neck dissections - 172 clinically N0 (cN0) and 273 clinically positive (cN+).
Neck levels cN0  cN+
Ia 3 (1,7%) 18 (6,6%)
Ib 11 (6,4%) 64 (23,4%)
IIa 35 (20,3%) 122 (44,7%)
IIb 7 (4,1%) 15 (5,5%)
III 18 (10,5%) 57 (20,9%)
IV 10 (5,8%) 27 (9,9%)
V 8 (4,6%) 16 (5,9%)
TOTAL  172  273
cN0 = no clinically palpable metastases, cN+ = clinically palpable metastases
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Table 4. Distribution of lymph node involvement in different levels of the neck according to clinical staging.
Levels
Staging (number of neck dissections)
cN1 - 122 cN2a - 22 cN2b - 67 cN2c - 41 cN3 - 19
Ia 4 (3,3%) 1 (4,5%) 6 (8,9%) 6 (14,6%) 1 (5,3%)
Ib 31 (25,4%) 2 (9,1%) 16 (23,9%) 10 (24,4%) 4 (21,0%)
IIa 51 (41,8%) 15 (68,2%) 33 (49,2%) 15 (36,6%) 7 (36,8%)
IIb 5 (4,1%)  0 7 (10,4%)  0 3 (15,8%)
III 18 (14,7%) 4 (18,2%) 20 (29,8%) 8 (19,5%) 6 (31,6%)
IV 12 (9,8%) 1 (4,5%) 5 (7,5%) 6 (14,6%) 3 (15,8%)
V 4 (3,3%) 2 (9,1%) 6 (8,9%) 2 (4,9%) 2 (10,5%)
cN = clinical staging of lymph node metastases - TNM
Table 5. Distribution of lymph node involvement in neck levels and sub-levels in 387 patients undergoing radical neck dissection for tongue, 
gingiva, floor of the mouth and retromolar tumors, in cN0 and cN+ cases.
 Ia Ib IIa IIb III IV V
RETR N0 0 2 11 1 2 3 1
RETR N+ 2 8 17 2 3 0 1
SOAL N0 1 4 9 1 5 1 4
SOAL N+ 7 26 38 5 28 12 7
GENG N0 2 4 6 2 2 3 0
GENG N+ 5 14 14 0 3 3 1
LÍNG N0 0 1 9 3 9 3 3
LÍNG N+ 4 10 44 8 20 11 7
N0 = no clinically palpable metastases, N+ = clinically palpable metastases
RETR = retromolar region, SOAL = floor of the mouth, GENG = gingiva, LING = tongue
Table 6. Local recurrence (RL), regional recurrence (RR) and local-
regional recurrence (RL + RR) in pN0 patients undergoing suprao-
mohyoid neck dissection.
Neck dissection(n) RL RR RL + RR
ESOH (48) 12 (25,0%) 4 (8,3%) 5 (10,4%)
EC + ESOH (13) 2 (15,4%) 1 (7,7%) 2 (15,4%)
ESOHB (10) 2 (20,0%) 1 (10,0%)  0
ESOH = unilateral supraomohyoid neck dissection; EC + ESOH = 
radical neck dissection + supraomohyoid neck dissection; ESOHB = 
bilateral supraomohyoid neck dissection.
Table 7. Local recurrence (RL). regional recurrence (RR) and local-
regional recurrence (RL + RR) in pN+ patients undergoing suprao-
mohyoid neck dissection
Neck dissection(n) RL RR RL + RR
ESOH (9) 2 (22,2%) 1 (11,1%) 1 (11,1%)
EC + ESOH (25) 6 (24,0%) 4 (16,0%) 1 (4,0%)
ESOHB (6) 2 (33,3%)  0  0
ESOH = unilateral supraomohyoid neck dissection; EC + ESOH = 
radical neck dissection + supraomohyoid neck dissection; ESOHB = 
bilateral supraomohyoid neck dissection.
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which 6 cases (7.3%) were pN0 and 3 cases were pN+ 
(6.5%). Recurrence was within the dissected area in 2 of 
the 6 pN0 cases, and in the contralateral side of the neck 
in 2 cases; none of these cases were irradiated. In 3 pN+ 
recurrence cases one occurred within the dissected area, 
another case was ipsilateral, not in the dissected area (no 
adjuvant radiotherapy was used in these two cases), and 
a third case recurred in the contralateral side of the neck 
(this patient underwent postoperative radiotherapy). In 22 
pN+ patients there were level Ia metastases in 5 cases, Ib 
metastases in 6 cases, IIa metastases in 8 cases and level 
III metastases in 7 cases. Table 7 shows local (RL), regional 
(RR) and local-regional (RL+RR) recurrences in this group. 
There was no statistically significant difference between 
the absence (pN0) and presence (pN+) of metastases on 
histology and the diagnosis of isolated regional recurrence 
(Table 8) as a function of neck dissection. Finally, there 
was no significance in the incidence of isolated unilateral 
events in 230 unilateral neck dissections (p=1.0). Radio-
therapy was done in 9 cases (5.6%) of recurrence out of 
160 neck dissections; 4 cases of recurrence (5.7%) out of 
70 were not irradiated.
DISCUSSION
One of the methods of assessing the feasibility of 
therapeutic selective (supraomohyoid) neck dissection is 
to study the distribution of cN0 and cN+ levels in the 445 
radical neck dissections (Table 3). Level IV was seen in 
9.9% of cases and level V was seen in 5.9% of cases; Shah 
found a 3% rate of level IV involvement for N0 cases and 
15% for N+ cases. This author also noted that level V was 
rarely involved and was always accompanied by metas-
tases in other lymph node levels. Based on this analysis 
three forms or recurrence were defined in or out of the 
dissected area and unilateral or contralateral. Our results 
were 3.9% in radical neck dissection and 5.1% in suprao-
mohyoid neck dissection; these results are similar to those 
reported in the literature9,12 in which the respective values 
are 9.3% and 10.2%. Our analysis of recurrence and the 
presence of metastases verified on histology, we found 
3.5% for pN0, and 4.7% for pN+, while these numbers in 
the literature are 5% and 10%.19
In cases of recurrence, 5,6% of cases underwent 
radiotherapy and 5,7% of cases had no radiotherapy, which 
is similar to the literature.5,14,20-22
We concluded that the choice of supraomohyoid 
neck dissection for squamous cell carcinoma in the lower 
region of the mouth is feasible without compromising 
oncological results.
CONCLUSION
The choice of selective neck dissection in levels I to 
IV in cases of squamous cell carcinoma in the lower region 
of the mouth associated with palpable metastases at level 
I is feasible without loss of oncological results.
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